The purpose of the registry study is to collect long term safety and information on Humira (adalimumab) and on two immunomodulator medications, azathioprine and 6-mercaptopurine, which are treatments for moderate to severely active ulcerative colitis. You were enrolled in this study since your doctor has prescribed one or more of these approved medications for the treatment of your ulcerative colitis.
This study is currently enrolling.
Interested in participating?
Fill out the information below and we will reach out to you within two business days with more information on qualifications for this trial and how to participate.